Methods to Produce Monoclonal Antibodies for the Prevention and Treatment of Viral Infections

por Merkuleva, Yu. A., Shcherbakov, D. N., Ilyichev, A. A.
Publicado 2022

mRNA Vaccine Platform: mRNA Production and Delivery

por Litvinova, V. R., Rudometov, A. P., Karpenko, L. I., Ilyichev, A. A.
Publicado 2023

Broadly Neutralizing Antibodies against HIV-1 As a Novel Aspect of the Immune Response

por Shcherbakov, D. N., Bakulina, A. Y., Karpenko, L. I., Ilyichev, A. A.
Publicado 2015

mRNA technology as one of the promising platforms for the SARS-CoV-2 vaccine development

por Ilyichev, A.A., Orlova, L.A., Sharabrin, S.V., Karpenko, L.I.
Publicado 2020

Model systems of human immunodef iciency virus (HIV-1) for in vitro eff icacy assessment of candidate vaccines and drugs against HIV-1

por Rudometova, N.B., Shcherbakov, D.N., Rudometov, A.P., Ilyichev, A.A., Karpenko, L.I.
Publicado 2022

The Structural and Immunological Properties of Chimeric Proteins Containing HIV-1 MPER Sites

por Rudometov, A. P., Rudometova, N. B., Shcherbakov, D. N., Lomzov, A. A., Kaplina, O. N., Shcherbakova, N. S., Ilyichev, A. A., Bakulina, A. Yu., Karpenko, L. I.
Publicado 2019

Immunogenic Properties of the DNA Construct Encoding the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein

por Borgoyakova, M. B., Karpenko, L. I., Rudometov, A. P., Shanshin, D. V., Isaeva, A. A., Nesmeyanova, V. S., Volkova, N. V., Belenkaya, S. V., Murashkin, D. E., Shcherbakov, D. N., Volosnikova, E. A., Starostina, E. V., Orlova, L. A., Danilchenko, N. V., Zaikovskaya, A. V., Pyankov, O. V., Ilyichev, A. A.
Publicado 2021

Immunogenicity of the DNA/Protein Combined Vaccine against COVID-19

por Borgoyakova, M. B., Karpenko, L. I., Merkulyeva, I. A., Shcherbakov, D. N., Rudometov, A. P., Starostina, E. V., Shanshin, D. V., Isaeva, A. A., Nesmeyanova, V. S., Volkova, N. V., Belenkaya, S. V., Volosnikova, E. A., Zadorozhny, A. M., Orlova, L. A., Zaykovskaya, A. V., Pyankov, O. V., Bazhan, S. I., Ilyichev, A. A.
Publicado 2023